Loading…

Postoperative Radiation Therapy in Oral Cavity Verrucous Carcinoma

Objectives/Hypothesis We investigate the clinicopathologic and treatment factors associated with the use of postoperative radiation therapy (PORT) and its effect on overall survival (OS) for patients with oral cavity verrucous carcinoma (VC). Study Design Retrospective cohort study. Methods A retros...

Full description

Saved in:
Bibliographic Details
Published in:The Laryngoscope 2022-10, Vol.132 (10), p.1953-1961
Main Authors: Naik, Akash N., Silverman, Dustin A., Rygalski, Chandler J., Zhao, Songzhu, Brock, Guy, Lin, Chen, Puram, Sidharth V., Rocco, James W., Baliga, Sujith, VanKoevering, Kyle K., Old, Matthew O., Seim, Nolan B., Kang, Stephen Y.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3579-c4988105aef38a1fcd48ca91137b17c69346de773065793b739a83d8283aad033
cites cdi_FETCH-LOGICAL-c3579-c4988105aef38a1fcd48ca91137b17c69346de773065793b739a83d8283aad033
container_end_page 1961
container_issue 10
container_start_page 1953
container_title The Laryngoscope
container_volume 132
creator Naik, Akash N.
Silverman, Dustin A.
Rygalski, Chandler J.
Zhao, Songzhu
Brock, Guy
Lin, Chen
Puram, Sidharth V.
Rocco, James W.
Baliga, Sujith
VanKoevering, Kyle K.
Old, Matthew O.
Seim, Nolan B.
Kang, Stephen Y.
description Objectives/Hypothesis We investigate the clinicopathologic and treatment factors associated with the use of postoperative radiation therapy (PORT) and its effect on overall survival (OS) for patients with oral cavity verrucous carcinoma (VC). Study Design Retrospective cohort study. Methods A retrospective cohort study of the National Cancer Database (NCDB) from 2006 to 2015 was performed. Multivariable logistic regression was used to identify independent predictive factors associated with the use of PORT. Cox Regression survival and propensity score analyses were used to evaluate the effect of PORT on mortality. Results A total of 356 adult patients with primary oral cavity VC who underwent definitive surgical resection were identified. A total of 10.7% of patients underwent definitive surgical resection followed by PORT. Variables associated with PORT included distance to the hospital per 10 miles (adjusted odds ratio [aOR], 0.81 [95% confidence interval (CI), 0.70–0.95]) and stage III–IV disease (aOR, 12.13 and 23.92, respectively). Multivariable Cox regression survival analysis indicated no evidence of survival benefit in patients undergoing PORT compared to surgery alone (adjusted hazard ratio 1.50 [0.74–3.05], P = .23). Propensity score analysis also showed no OS benefit with the use of PORT (P = .41). Conclusions Variables associated with the use of PORT on multivariable analysis included closer distance to hospital and stage III–IV disease. No clear survival benefit with PORT was identified on either multivariable survival analysis or propensity score analysis. These results suggest that surgery alone with negative margins may be the optimal treatment for patients with oral cavity VC. Level of Evidence 4 Laryngoscope, 132:1953–1961, 2022
doi_str_mv 10.1002/lary.30009
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2617276409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2712698267</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3579-c4988105aef38a1fcd48ca91137b17c69346de773065793b739a83d8283aad033</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMobk5v_AFS8EaEaj7aJrmcwy8YTMYUvQpZmmJG28yknfTfm9nphRdencM5D-85PACcIniFIMTXpXTdFYEQ8j0wRClBccJ5ug-GYUliluLXATjyfgUhoiSFh2BAEs54AukQ3DxZ39i1drIxGx3NZW5CZ-to8R5m6y4ydTRzsowmcmOaLnrRzrXKtj4MnDK1reQxOChk6fXJro7A893tYvIQT2f3j5PxNFYkpTxW4SZDMJW6IEyiQuUJU5IjROgSUZVxkmS5ppTALOBkSQmXjOQMMyJlDgkZgYs-d-3sR6t9IyrjlS5LWevwkMAZophmCeQBPf-Drmzr6vCdwBThjDOc0UBd9pRy1nunC7F2pgoyBYJia1ZszYpvswE-20W2y0rnv-iPygCgHvg0pe7-iRLT8fytD_0CP26Bwg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2712698267</pqid></control><display><type>article</type><title>Postoperative Radiation Therapy in Oral Cavity Verrucous Carcinoma</title><source>Wiley</source><creator>Naik, Akash N. ; Silverman, Dustin A. ; Rygalski, Chandler J. ; Zhao, Songzhu ; Brock, Guy ; Lin, Chen ; Puram, Sidharth V. ; Rocco, James W. ; Baliga, Sujith ; VanKoevering, Kyle K. ; Old, Matthew O. ; Seim, Nolan B. ; Kang, Stephen Y.</creator><creatorcontrib>Naik, Akash N. ; Silverman, Dustin A. ; Rygalski, Chandler J. ; Zhao, Songzhu ; Brock, Guy ; Lin, Chen ; Puram, Sidharth V. ; Rocco, James W. ; Baliga, Sujith ; VanKoevering, Kyle K. ; Old, Matthew O. ; Seim, Nolan B. ; Kang, Stephen Y.</creatorcontrib><description>Objectives/Hypothesis We investigate the clinicopathologic and treatment factors associated with the use of postoperative radiation therapy (PORT) and its effect on overall survival (OS) for patients with oral cavity verrucous carcinoma (VC). Study Design Retrospective cohort study. Methods A retrospective cohort study of the National Cancer Database (NCDB) from 2006 to 2015 was performed. Multivariable logistic regression was used to identify independent predictive factors associated with the use of PORT. Cox Regression survival and propensity score analyses were used to evaluate the effect of PORT on mortality. Results A total of 356 adult patients with primary oral cavity VC who underwent definitive surgical resection were identified. A total of 10.7% of patients underwent definitive surgical resection followed by PORT. Variables associated with PORT included distance to the hospital per 10 miles (adjusted odds ratio [aOR], 0.81 [95% confidence interval (CI), 0.70–0.95]) and stage III–IV disease (aOR, 12.13 and 23.92, respectively). Multivariable Cox regression survival analysis indicated no evidence of survival benefit in patients undergoing PORT compared to surgery alone (adjusted hazard ratio 1.50 [0.74–3.05], P = .23). Propensity score analysis also showed no OS benefit with the use of PORT (P = .41). Conclusions Variables associated with the use of PORT on multivariable analysis included closer distance to hospital and stage III–IV disease. No clear survival benefit with PORT was identified on either multivariable survival analysis or propensity score analysis. These results suggest that surgery alone with negative margins may be the optimal treatment for patients with oral cavity VC. Level of Evidence 4 Laryngoscope, 132:1953–1961, 2022</description><identifier>ISSN: 0023-852X</identifier><identifier>EISSN: 1531-4995</identifier><identifier>DOI: 10.1002/lary.30009</identifier><identifier>PMID: 34989407</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Cohort analysis ; Head &amp; neck cancer ; head and neck cancer ; Laryngoscopy ; National Cancer Database ; Oral cancer ; Oral cavity ; postoperative radiation therapy ; Radiation therapy ; Survival analysis ; verrucous carcinoma</subject><ispartof>The Laryngoscope, 2022-10, Vol.132 (10), p.1953-1961</ispartof><rights>2022 The American Laryngological, Rhinological and Otological Society, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3579-c4988105aef38a1fcd48ca91137b17c69346de773065793b739a83d8283aad033</citedby><cites>FETCH-LOGICAL-c3579-c4988105aef38a1fcd48ca91137b17c69346de773065793b739a83d8283aad033</cites><orcidid>0000-0003-3569-6637 ; 0000-0001-5921-7042 ; 0000-0003-3543-889X ; 0000-0002-0865-6149</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34989407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Naik, Akash N.</creatorcontrib><creatorcontrib>Silverman, Dustin A.</creatorcontrib><creatorcontrib>Rygalski, Chandler J.</creatorcontrib><creatorcontrib>Zhao, Songzhu</creatorcontrib><creatorcontrib>Brock, Guy</creatorcontrib><creatorcontrib>Lin, Chen</creatorcontrib><creatorcontrib>Puram, Sidharth V.</creatorcontrib><creatorcontrib>Rocco, James W.</creatorcontrib><creatorcontrib>Baliga, Sujith</creatorcontrib><creatorcontrib>VanKoevering, Kyle K.</creatorcontrib><creatorcontrib>Old, Matthew O.</creatorcontrib><creatorcontrib>Seim, Nolan B.</creatorcontrib><creatorcontrib>Kang, Stephen Y.</creatorcontrib><title>Postoperative Radiation Therapy in Oral Cavity Verrucous Carcinoma</title><title>The Laryngoscope</title><addtitle>Laryngoscope</addtitle><description>Objectives/Hypothesis We investigate the clinicopathologic and treatment factors associated with the use of postoperative radiation therapy (PORT) and its effect on overall survival (OS) for patients with oral cavity verrucous carcinoma (VC). Study Design Retrospective cohort study. Methods A retrospective cohort study of the National Cancer Database (NCDB) from 2006 to 2015 was performed. Multivariable logistic regression was used to identify independent predictive factors associated with the use of PORT. Cox Regression survival and propensity score analyses were used to evaluate the effect of PORT on mortality. Results A total of 356 adult patients with primary oral cavity VC who underwent definitive surgical resection were identified. A total of 10.7% of patients underwent definitive surgical resection followed by PORT. Variables associated with PORT included distance to the hospital per 10 miles (adjusted odds ratio [aOR], 0.81 [95% confidence interval (CI), 0.70–0.95]) and stage III–IV disease (aOR, 12.13 and 23.92, respectively). Multivariable Cox regression survival analysis indicated no evidence of survival benefit in patients undergoing PORT compared to surgery alone (adjusted hazard ratio 1.50 [0.74–3.05], P = .23). Propensity score analysis also showed no OS benefit with the use of PORT (P = .41). Conclusions Variables associated with the use of PORT on multivariable analysis included closer distance to hospital and stage III–IV disease. No clear survival benefit with PORT was identified on either multivariable survival analysis or propensity score analysis. These results suggest that surgery alone with negative margins may be the optimal treatment for patients with oral cavity VC. Level of Evidence 4 Laryngoscope, 132:1953–1961, 2022</description><subject>Cohort analysis</subject><subject>Head &amp; neck cancer</subject><subject>head and neck cancer</subject><subject>Laryngoscopy</subject><subject>National Cancer Database</subject><subject>Oral cancer</subject><subject>Oral cavity</subject><subject>postoperative radiation therapy</subject><subject>Radiation therapy</subject><subject>Survival analysis</subject><subject>verrucous carcinoma</subject><issn>0023-852X</issn><issn>1531-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kF1LwzAUhoMobk5v_AFS8EaEaj7aJrmcwy8YTMYUvQpZmmJG28yknfTfm9nphRdencM5D-85PACcIniFIMTXpXTdFYEQ8j0wRClBccJ5ug-GYUliluLXATjyfgUhoiSFh2BAEs54AukQ3DxZ39i1drIxGx3NZW5CZ-to8R5m6y4ydTRzsowmcmOaLnrRzrXKtj4MnDK1reQxOChk6fXJro7A893tYvIQT2f3j5PxNFYkpTxW4SZDMJW6IEyiQuUJU5IjROgSUZVxkmS5ppTALOBkSQmXjOQMMyJlDgkZgYs-d-3sR6t9IyrjlS5LWevwkMAZophmCeQBPf-Drmzr6vCdwBThjDOc0UBd9pRy1nunC7F2pgoyBYJia1ZszYpvswE-20W2y0rnv-iPygCgHvg0pe7-iRLT8fytD_0CP26Bwg</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Naik, Akash N.</creator><creator>Silverman, Dustin A.</creator><creator>Rygalski, Chandler J.</creator><creator>Zhao, Songzhu</creator><creator>Brock, Guy</creator><creator>Lin, Chen</creator><creator>Puram, Sidharth V.</creator><creator>Rocco, James W.</creator><creator>Baliga, Sujith</creator><creator>VanKoevering, Kyle K.</creator><creator>Old, Matthew O.</creator><creator>Seim, Nolan B.</creator><creator>Kang, Stephen Y.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3569-6637</orcidid><orcidid>https://orcid.org/0000-0001-5921-7042</orcidid><orcidid>https://orcid.org/0000-0003-3543-889X</orcidid><orcidid>https://orcid.org/0000-0002-0865-6149</orcidid></search><sort><creationdate>202210</creationdate><title>Postoperative Radiation Therapy in Oral Cavity Verrucous Carcinoma</title><author>Naik, Akash N. ; Silverman, Dustin A. ; Rygalski, Chandler J. ; Zhao, Songzhu ; Brock, Guy ; Lin, Chen ; Puram, Sidharth V. ; Rocco, James W. ; Baliga, Sujith ; VanKoevering, Kyle K. ; Old, Matthew O. ; Seim, Nolan B. ; Kang, Stephen Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3579-c4988105aef38a1fcd48ca91137b17c69346de773065793b739a83d8283aad033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cohort analysis</topic><topic>Head &amp; neck cancer</topic><topic>head and neck cancer</topic><topic>Laryngoscopy</topic><topic>National Cancer Database</topic><topic>Oral cancer</topic><topic>Oral cavity</topic><topic>postoperative radiation therapy</topic><topic>Radiation therapy</topic><topic>Survival analysis</topic><topic>verrucous carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Naik, Akash N.</creatorcontrib><creatorcontrib>Silverman, Dustin A.</creatorcontrib><creatorcontrib>Rygalski, Chandler J.</creatorcontrib><creatorcontrib>Zhao, Songzhu</creatorcontrib><creatorcontrib>Brock, Guy</creatorcontrib><creatorcontrib>Lin, Chen</creatorcontrib><creatorcontrib>Puram, Sidharth V.</creatorcontrib><creatorcontrib>Rocco, James W.</creatorcontrib><creatorcontrib>Baliga, Sujith</creatorcontrib><creatorcontrib>VanKoevering, Kyle K.</creatorcontrib><creatorcontrib>Old, Matthew O.</creatorcontrib><creatorcontrib>Seim, Nolan B.</creatorcontrib><creatorcontrib>Kang, Stephen Y.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>The Laryngoscope</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Naik, Akash N.</au><au>Silverman, Dustin A.</au><au>Rygalski, Chandler J.</au><au>Zhao, Songzhu</au><au>Brock, Guy</au><au>Lin, Chen</au><au>Puram, Sidharth V.</au><au>Rocco, James W.</au><au>Baliga, Sujith</au><au>VanKoevering, Kyle K.</au><au>Old, Matthew O.</au><au>Seim, Nolan B.</au><au>Kang, Stephen Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Postoperative Radiation Therapy in Oral Cavity Verrucous Carcinoma</atitle><jtitle>The Laryngoscope</jtitle><addtitle>Laryngoscope</addtitle><date>2022-10</date><risdate>2022</risdate><volume>132</volume><issue>10</issue><spage>1953</spage><epage>1961</epage><pages>1953-1961</pages><issn>0023-852X</issn><eissn>1531-4995</eissn><abstract>Objectives/Hypothesis We investigate the clinicopathologic and treatment factors associated with the use of postoperative radiation therapy (PORT) and its effect on overall survival (OS) for patients with oral cavity verrucous carcinoma (VC). Study Design Retrospective cohort study. Methods A retrospective cohort study of the National Cancer Database (NCDB) from 2006 to 2015 was performed. Multivariable logistic regression was used to identify independent predictive factors associated with the use of PORT. Cox Regression survival and propensity score analyses were used to evaluate the effect of PORT on mortality. Results A total of 356 adult patients with primary oral cavity VC who underwent definitive surgical resection were identified. A total of 10.7% of patients underwent definitive surgical resection followed by PORT. Variables associated with PORT included distance to the hospital per 10 miles (adjusted odds ratio [aOR], 0.81 [95% confidence interval (CI), 0.70–0.95]) and stage III–IV disease (aOR, 12.13 and 23.92, respectively). Multivariable Cox regression survival analysis indicated no evidence of survival benefit in patients undergoing PORT compared to surgery alone (adjusted hazard ratio 1.50 [0.74–3.05], P = .23). Propensity score analysis also showed no OS benefit with the use of PORT (P = .41). Conclusions Variables associated with the use of PORT on multivariable analysis included closer distance to hospital and stage III–IV disease. No clear survival benefit with PORT was identified on either multivariable survival analysis or propensity score analysis. These results suggest that surgery alone with negative margins may be the optimal treatment for patients with oral cavity VC. Level of Evidence 4 Laryngoscope, 132:1953–1961, 2022</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>34989407</pmid><doi>10.1002/lary.30009</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-3569-6637</orcidid><orcidid>https://orcid.org/0000-0001-5921-7042</orcidid><orcidid>https://orcid.org/0000-0003-3543-889X</orcidid><orcidid>https://orcid.org/0000-0002-0865-6149</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0023-852X
ispartof The Laryngoscope, 2022-10, Vol.132 (10), p.1953-1961
issn 0023-852X
1531-4995
language eng
recordid cdi_proquest_miscellaneous_2617276409
source Wiley
subjects Cohort analysis
Head & neck cancer
head and neck cancer
Laryngoscopy
National Cancer Database
Oral cancer
Oral cavity
postoperative radiation therapy
Radiation therapy
Survival analysis
verrucous carcinoma
title Postoperative Radiation Therapy in Oral Cavity Verrucous Carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T03%3A03%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Postoperative%20Radiation%20Therapy%20in%20Oral%20Cavity%20Verrucous%20Carcinoma&rft.jtitle=The%20Laryngoscope&rft.au=Naik,%20Akash%20N.&rft.date=2022-10&rft.volume=132&rft.issue=10&rft.spage=1953&rft.epage=1961&rft.pages=1953-1961&rft.issn=0023-852X&rft.eissn=1531-4995&rft_id=info:doi/10.1002/lary.30009&rft_dat=%3Cproquest_cross%3E2712698267%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3579-c4988105aef38a1fcd48ca91137b17c69346de773065793b739a83d8283aad033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2712698267&rft_id=info:pmid/34989407&rfr_iscdi=true